"It would be great to see if management releases a press release once 250 MACE have been adjudicated , I think that would start to gte the SP moving up in anticipation of good results or maybe an 8th and final DSMB might get thing going possible,  we do need some sort of news IMO before years end"

What we most likely (no guarantee) will see is:

1) 8th DSMB announcement. Last one was August 7th. Very likely next one comes in December.

2) News release/announcement that 250 non-adjudicated events have occured, triggering the end of dosing and commencement of patient follow up period and final adjudication. Latest company guidance for this end of dosing announcement is by end of year. December 2018 is possible, but don't be surprised if this doesn't happen until early 2019. Latest company guidance was that it would take ~ 2 months for safety follow ups and adjudication.

3a) Announcement of top-line results once 250 events have been adjudicated. Latest company guidance was that it would take ~ 2 months for safety follow ups and adjudication. So most likely top-line Q1 2019 with full data presentation at a conference in Q2 or Q3 2019. But all depends on when the 250 non-adjudicated mark is hit and when dosing ends.

3b) Alternatively, ACC 2019 presents an interesting scenario (9 days left to submit!). Both top-line and full data (presentation and publication) could be announced/presented at ACC in March 2019.

BDAZ